SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Sepsis/Acute Inflammation

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche10/20/2014 7:47:13 PM
   of 89
 
cool....

Immunobiology. 2014 Sep 28. pii: S0171-2985(14)00178-8. doi: 10.1016/j.imbio.2014.09.017. [Epub ahead of print]
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism.
Fallarino F1, Pallotta MT2, Matino D2, Gargaro M2, Orabona C2, Vacca C2, Mondanelli G2, Allegrucci M2, Boon L3, Romani R4, Talesa VN4, Puccetti P2, Grohmann U5.

  • 1Department of Experimental Medicine, University of Perugia, Perugia, Italy. Electronic address: fllfnc@tin.it.
  • 2Department of Experimental Medicine, University of Perugia, Perugia, Italy.
  • 3Bioceros, Utrecht, The Netherlands.
  • 4Department of Experimental Medicine, University of Perugia, Perugia, Italy; Bioceros, Utrecht, The Netherlands.
  • 5Department of Experimental Medicine, University of Perugia, Perugia, Italy. Electronic address: ugrohmann@tin.it.


  • Abstract
    Dendritic cells (DCs) are specialized antigen-presenting cells with a bipolar nature. Depending on environmental factors, DCs will promote either inflammatory or anti-inflammatory effects. Lipopolysaccharide (LPS), a ligand of Toll-like receptor (TLR)4 and a most potent proinflammatory stimulus, is responsible for complex signaling events in different cell types, including DCs. LPS effects range from protective inflammation-capable of counteracting growth and dissemination of gram-negative bacteria - to hyperacute detrimental responses, as it occurs in endotoxic shock. Consistent with the plasticity of TLR4 signaling, a low dosage of LPS will induce a regulatory response capable of protecting mice against a subsequent, otherwise lethal challenge ('endotoxin tolerance'). By examining CD11c+ DCs ('conventional' DCs, or cDCs), we investigated whether DC flexibility in promoting either inflammation or tolerance can be differentially affected by single vs. repeated exposure to LPS in vitro. cDCs stimulated twice with LPS expressed high levels of indoleamine 2,3-dioxygenase 1 (IDO1) - one of the most effective mediator of anti-inflammatory activity by DCs - and of TGF-ß, an immunoregulatory cytokine capable of upregulating IDO1 expression and function. In contrast, a single exposure to LPS failed to upregulate IDO1, and it was instead associated with high-level production of IL-6, a cytokine that promotes inflammation and proteolysis ofIDO1. When adoptively transferred in vivo, only cDCs on double endotoxin exposure greatly improved the outcome of an otherwise lethal LPS challenge. The protective effect required that the transferred cDCs be fully competent for IDO1 and the host for TGF-ß production. Thus cDCs, conditioned by LPS in vitro to mimic an endotoxin-tolerant state, can protect recipients from endotoxic shock, pointing to adoptive transfer of tolerance as a new option for controlling potentially harmful responses to TLR4 signaling.
    Report TOU ViolationShare This Post
     Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext